Skip to main content

Advertisement

SpringerLink
Log in

Association of serum level of chemerin with visceral fat obesity in type 2 diabetic patient

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Aim and objective

This study aimed to investigate whether circulating chemerin levels might be associated with visceral obesity and other metabolic parameters in subject with newly diagnosed type 2 diabetes.

Methodology

The study was conducted at Baqai Institute of Diabetology and Endocrinology (BIDE), Baqai Medical University (BMU), Karachi. The study was carried out after ethical approval from ethics committee of BMU. Type 2 diabetic subjects ≥ 20 years of age and without any complication were included whereas subjects with type I diabetes mellitus, gestational diabetes, and acute or chronic illness were excluded. A total of 75 subjects participated in the study and were divided into three groups, (n=25) normal glucose tolerance (NGT), (n=25) type 2 diabetes (T2DM), and (n=25) impaired glucose tolerance (IGT) according to oral glucose tolerance test (OGTT) [1].

Results

A total of 75 subjects participated in the study, out of which 25 subjects were newly diagnosed with type 2 diabetes (T2DM) and 25 subjects had impaired glucose tolerance (IGT) while 25 individuals had normal glucose tolerance (NGT). Subjects with NGT had significantly lower FBS and RBS level than subjects with IGT and T2DM. HbA1c was significantly higher in subjects with T2DM whereas chemerin level was significantly lower in T2DM as compared to subjects with NGT and IGT. Among subjects with T2DM, it was observed that only HbA1c had positively strong correlation with chemerin level (r=0.645, p=0.001) while FBS had positively moderate correlation with chemerin level (r=0.471, p=0.017). Correlation of chemerin with diastolic blood pressure, RBS, and HDL was also moderate but non-significant.

Conclusion

Newly diagnosed diabetic subjects had low serum chemerin levels with obesity compared to healthy individuals, which could indicate a possibility of lifestyle modification practice in T2DM subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

No further data is available.

References

  1. American diabetes association. Available at: https://www.diabetes.org/a1c/diagnosis. Last assessed at: 1 November 2020

  2. Qiao Q, Nyamdorj R. Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index? Eur J Clin Nutr. 2010;64(1):30–4. https://doi.org/10.1038/ejcn.2009.93.

    Article  CAS  PubMed  Google Scholar 

  3. Basit A, Askari S, Zafar J, Riaz M, Fawwad A, Members ND. NDSP 06: Prevalence and risk factors for obesity in urban and rural areas of Pakistan: a study from second National Diabetes Survey of Pakistan (NDSP), 2016–2017. Obes Res Cli Pract. 2020.

  4. Stefanov T, Blüher M, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, Temelkova-Kurktschiev T. Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine. 2014;45:382–91. https://doi.org/10.1007/s12020-013-0003-2.

    Article  CAS  PubMed  Google Scholar 

  5. Zhang M, Chen P, Chen S, Sun Q, Zeng QC, Chen JY, Liu YX, Cao XH, Ren M, Wang JK. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study. Eur Rev Med Pharmacol Sci. 2014;18:1567–72.

    CAS  PubMed  Google Scholar 

  6. Gu P, Jiang W, Lu B, Shi Z. Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension subjectss. Clin Exp Hypertens. 2014;36(5):326–32. https://doi.org/10.3109/10641963.2013.827697.

    Article  CAS  PubMed  Google Scholar 

  7. Aksu F, Caliskan M, Keles N, Toprak EA, Uzuncakmak KT, Kostek O, et al. Chemerin as a marker of subclinical cardiac involvement in psoriatic subjects. Cardiol J. 2017;24(3):276–83. https://doi.org/10.5603/CJ.a2017.0031.

    Article  PubMed  Google Scholar 

  8. Cheon DY, Kang JG, Lee SJ, Ihm SH, Lee EJ, Choi MG, Yoo HJ, Kim CS. Serum chemerin levels are associated with visceral adiposity, independent of waist circumference, in newly diagnosed type 2 diabetic subjects. Yonsei Med J. 2017;58(2):319–25. https://doi.org/10.3349/ymj.2017.58.2.319.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Basit A, Fawwad A, Qureshi H, NDSP Members, et al. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016–2017. BMJ Open. 2018;8:e020961.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sharma SP, Anjankar AP, Kale A. Comparison of glucose levels using glucometer and GOD-POD method in diabetic subjects. Indian J Clin Biochem Res. 2017;4(1):6–10. https://doi.org/10.18231/2394-6377.2017.0002.

    Article  Google Scholar 

  11. Fawwad A, Sabir R, Riaz M, Moin H, Basit A. Measured versus calculated LDL-cholesterol in subjects with type 2 diabetes. Pak J Med Sci. 2016;32(4):955–60. https://doi.org/10.12669/pjms.324.989.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Fatima SS, Butt Z, Bader N, Pathan AZ, Hussain S, Iqbal NT. Role of multifunctional chemerin in obesity and preclinical diabetes. Obes Res Clin Pract. 2015;9(5):507–12. https://doi.org/10.1016/j.orcp.2015.01.004.

    Article  PubMed  Google Scholar 

  13. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148(10):4687–94. https://doi.org/10.1210/en.2007-0175.

    Article  CAS  PubMed  Google Scholar 

  14. Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21(5):360–5. https://doi.org/10.1097/MCO.0000000000000485.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Han J, Kim SH, Suh YJ, Lim HA, Shin H, Cho SG, Kim CW, Lee SY, Lee DH, Hong S, Kim YS, Nam MS. Serum chemerin levels are associated with abdominal visceral fat in type 2 diabetes. J Korean Med Sci. 2016;31(6):924–31. https://doi.org/10.3346/jkms.2016.31.6.924.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bigna JJ, Bahebeck J, Sobngwi E, Mbanya JC. Metabolic syndrome for sub-Saharan Africans diabetes with peripheral arterial disease: a case-control study. BMC Rese Notes. 2014;7(1):104. https://doi.org/10.1186/1756-0500-7-104.

    Article  Google Scholar 

  17. Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and non-alcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223. https://doi.org/10.3390/ijms15046184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Yang M, Yang G, Dong J, Liu Y, Zong H, Liu H, Boden G, Li L. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J Investig Med. 2010;58(7):883–6. https://doi.org/10.2310/JIM.0b013e3181ec5db2.

    Article  CAS  PubMed  Google Scholar 

  19. Yang M, Zhou X, Xu J, Yang B, Yu J, Gong Q, et al. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio. Bosn J Basic Med Sci. 2019;19(4):328–35. https://doi.org/10.17305/bjbms.2019.4002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Baqai Medical University, Karachi, Pakistan

    Shaheena Qazi, Iftikhar Ahmed Siddiqui, Muhammad Saeed, Kahkashan Perveen & Asher Fawwad

  2. Research Department, Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Plot No. 1-2, II-B, Nazimabad No2, Karachi, 74600, Pakistan

    Kulsoom Baqa & Asher Fawwad

Authors
  1. Shaheena Qazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iftikhar Ahmed Siddiqui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muhammad Saeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kahkashan Perveen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kulsoom Baqa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Asher Fawwad
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S Qazi: concept and design, interpretation of data and wrote the manuscript

IA Siddiqui: concept and design, edited and approved the manuscript

M Saeed: concept and design, edited and approved the manuscript

K Perveen: interpretation of data, wrote, edited and reviewed the manuscript

K Baqa: interpretation of data, wrote and reviewed the manuscript

A Fawwad: concept and design, edited and approved the manuscript

Corresponding author

Correspondence to Asher Fawwad.

Ethics declarations

Ethics approval

The study was carried out after ethical approval from ethics committee of BMU.

Consent to participate

Written informed consent was obtained from study subjects.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qazi, S., Siddiqui, I.A., Saeed, M. et al. Association of serum level of chemerin with visceral fat obesity in type 2 diabetic patient. Int J Diabetes Dev Ctries 43, 298–303 (2023). https://doi.org/10.1007/s13410-022-01066-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-022-01066-3

Keywords

Search

Navigation